Masaji Matsuoka
Private-Equity-Analyst bei Mitsui & Co. Global Investment, Inc.
Aktive Positionen von Masaji Matsuoka
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Mitsui & Co. Global Investment, Inc.
 Mitsui & Co. Global Investment, Inc. Investment ManagersFinance Mitsui & Co. Global Investment, Inc. (Mitsui & Co. Global Investment) is a venture capital subsidiary of Mitsui Ventures founded in 1999. The firm is headquartered in Menlo Park, California. | Private-Equity-Analyst | 15.04.2010 | - |
Karriereverlauf von Masaji Matsuoka
Ehemalige bekannte Positionen von Masaji Matsuoka
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
ArmaGen, Inc.
 ArmaGen, Inc. Hospital/Nursing ManagementHealth Services ArmaGen, Inc. engages in operation of a clinical stage biotechnology company focused on developing revolutionary therapies for severe neurological disorders. Its products include AGT-110-Brain-penetrating biologic tumor necrosis factor inhibitor (TNFI) for Alzheimer's disease, AGT-115-Brain-penetrating erythropoietin (EPO) for stroke, AGT-160-Brain penetrating anti-amyloid antibody (AAA) for Alzheimer's disease and AGT-181-Brain-penetrating iduronidase (IDUA) for Mucopolysaccharidosis (MPS) Type I (Hurler's syndrome). The company was founded by William M. Pardridge and Ruben J. Boado in 2003 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | - | - |
Ausbildung von Masaji Matsuoka
| University of Tokyo | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
| Japan | 2 |
Operativ
| Private Equity Analyst | 1 |
| Undergraduate Degree | 1 |
| Director/Board Member | 1 |
Sektoral
| Finance | 2 |
| Consumer Services | 2 |
| Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Mitsui & Co. Global Investment, Inc.
Mitsui & Co. Global Investment, Inc. Investment ManagersFinance Mitsui & Co. Global Investment, Inc. (Mitsui & Co. Global Investment) is a venture capital subsidiary of Mitsui Ventures founded in 1999. The firm is headquartered in Menlo Park, California. | Finance |
ArmaGen, Inc.
ArmaGen, Inc. Hospital/Nursing ManagementHealth Services ArmaGen, Inc. engages in operation of a clinical stage biotechnology company focused on developing revolutionary therapies for severe neurological disorders. Its products include AGT-110-Brain-penetrating biologic tumor necrosis factor inhibitor (TNFI) for Alzheimer's disease, AGT-115-Brain-penetrating erythropoietin (EPO) for stroke, AGT-160-Brain penetrating anti-amyloid antibody (AAA) for Alzheimer's disease and AGT-181-Brain-penetrating iduronidase (IDUA) for Mucopolysaccharidosis (MPS) Type I (Hurler's syndrome). The company was founded by William M. Pardridge and Ruben J. Boado in 2003 and is headquartered in San Diego, CA. | Health Services |
- Börse
- Insiders
- Masaji Matsuoka
- Erfahrung
